Drug Pipeline

Anti-CD19-CAR CMV-specific T-lymphocytes Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 1
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT05432635 Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA… B-Cell Non-Hodgkin Lymphoma Recruiting
NCT05801913 Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA… High Grade B-Cell Non-Hodgkin's Lymphoma Recruiting
Early Phase 1
NCT06735690 Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched… Acute Lymphoblastic Leukemia Recruiting
Sponsors Running Anti-CD19-CAR CMV-specific T-lymphocytes Trials
City of Hope Medical Center (3)
Disease Areas
Non-Hodgkin Lymphoma (2) DLBCL (1) Mantle Cell Lymphoma (1) Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when Anti-CD19-CAR CMV-specific T-lymphocytes trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free